HomeAVTE • NASDAQ
add
Aerovate Therapeutics Inc
Previous close
$20.84
Day range
$20.21 - $21.21
Year range
$9.41 - $32.42
Market cap
596.87M USD
Avg Volume
189.56K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 22.07M | 39.20% |
Net income | -20.41M | -35.89% |
Net profit margin | — | — |
Earnings per share | -0.74 | -21.31% |
EBITDA | -22.04M | -39.20% |
Effective tax rate | -0.28% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 122.44M | -5.25% |
Total assets | 127.42M | -5.83% |
Total liabilities | 17.96M | 109.89% |
Total equity | 109.46M | — |
Shares outstanding | 27.86M | — |
Price to book | 5.29 | — |
Return on assets | -41.12% | — |
Return on capital | -46.62% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -20.41M | -35.89% |
Cash from operations | -14.80M | 0.44% |
Cash from investing | 5.65M | -61.01% |
Cash from financing | 463.00K | 29.69% |
Net change in cash | -8.69M | -39,395.45% |
Free cash flow | -7.02M | 9.85% |
About
Founded
2018
Headquarters
Website
Employees
51